GLP-1 receptor agonists are synthetic peptides that mimic endogenous GLP-1 to enhance insulin secretion, suppress glucagon, and reduce appetite
The more practical question is whether peptides can complement existing therapies and potentially allow reduction of treatments that cause long-term side effects
indeed, anybody who decides to lose weight by more conventional means does exactly the same
Mishra AP, Salehi B, Sharifi-Rad M, Pezzani R, Kobarfard F, Sharifi-Rad J, et al
BPC 157 maintains the normal functions of cells by enhancing their antioxidant capacity and protecting them from the attack of free radicals
One commonly overlooked contributor is Small Intestinal Bacterial Overgrowth (SIBO), a condition in which excessive bacteria accumulate in the small intestine